We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Bioinformatics Expansion Heralds Further Growth for Almac

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Bioinformatics Expansion Heralds Further Growth for Almac"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Almac has shown significant growth in the last year, with employee numbers growing by 15% in the UK and 10% in the US. For the Diagnostics division, this trend continues through the expansion of the Bioinformatics Department and the subsequent opening of a dedicated bioinformatics facility in Manchester (UK).

Professor Paul Harkin, President and Managing Director of Almac Diagnostics said:  “With our commitment to the delivery of personalized medicine, we have extended our bioinformatics group to increase our expertise in companion diagnostic development, pharmacodynamic (PD) biomarkers, disease classification and prognostic markers. Our extended expert bioinformatics capability assists our dedication to the advancement of patient care through translational genomic solutions”

Almac’s Bioinformatics group specialise in gene selection, disease characterisation and classification. Bioinformatics is well recognised as a major bottleneck in genomics and the expansion of the bioinformatics group greatly expands Almac’s capacity and hence reduces this problem.

A video interview on the expansion with Professor Paul Harkin can be viewed at